Literature DB >> 25128749

Impaired coronary microvascular and left ventricular diastolic function in patients with inflammatory bowel disease.

Zuhal Caliskan1, Huseyin Savas Gokturk2, Mustafa Caliskan3, Hakan Gullu3, Ozgur Ciftci3, Gülsüm Teke Ozgur2, Aytekin Guven3, Haldun Selcuk2.   

Abstract

BACKGROUND AND AIM: Increased incidence of coronary vascular events in patients with inflammatory bowel disease (IBD) is known. However, the association between coronary microvascular function and IBD has not been fully defined. We aimed to investigate whether coronary flow reserve (CFR) and left ventricular diastolic function were impaired in IBD patients.
METHODS: Seventy-two patients with IBD (36 patients with ulcerative colitis [UC] and 36 Crohn's disease [CD]) were registered. Each subject was evaluated after a minimum 15-day attack-free period. For the control group, 36 age- and sex-matched healthy volunteers were included into the study. IBD clinical disease activity in UC was assessed by the Truelove-Witts Index (TWAS) and in CD by the Crohn's Disease Activity Index (CDAI). In each subject, CFR was measured through transthoracic Doppler echocardiography.
RESULTS: Compared to the controls, the CD group and UC group had significantly higher high-sensitivity C-reactive protein (hs-CRP) and erythrocyte sedimentation rate. Baseline diastolic peak flow velocity (DPFV) of the left anterior descending artery (LAD) was significantly higher in the IBD group (24.1±3.9 vs. 22. 4±2.9, p<0.05), and hyperemic DPFV (56.1±12.5 vs. 70.6±15.3, p<0.05) and CFR (2.34±0.44 vs. 3.14±0.54, p<0.05) were significantly lower in the IBD group than in the control group. In stepwise linear regression analysis, hs-CRP and lateral Em/Am ratio were independently correlated with CFR.
CONCLUSION: CFR, reflecting coronary microvascular function, is impaired in patients with IBD. CFR and left ventricular diastolic function parameters are well correlated with hs-CRP.
Copyright © 2014. Published by Elsevier Inc.

Entities:  

Keywords:  Atherosclerosis; Coronary flow reserve; Echocardiography; Inflammatory bowel disease; Microvascular function

Mesh:

Substances:

Year:  2014        PMID: 25128749     DOI: 10.1016/j.mvr.2014.08.003

Source DB:  PubMed          Journal:  Microvasc Res        ISSN: 0026-2862            Impact factor:   3.514


  10 in total

1.  The Impact of Prognostic Nutritional Index on Coronary Flow Reserve in Patients with Inflammatory Bowel Disease.

Authors:  Zuhal Caliskan; Mustafa Adem Tatlisu; Resul Kahraman; Savas Gokturk; Suleyman Sayar; Osman Kostek; Seref Kul; Omer Faruk Baycan; Fatma Gül Ozcan; Mustafa Caliskan
Journal:  Medeni Med J       Date:  2019-09-27

2.  Imparied retrobulbar blood flow and increased carotid IMT in patients with Crohn's disease.

Authors:  Zuhal Caliskan; Nursen Keles; Resul Kahraman; Kamil Özdil; Vildan Karagoz; Feyza Aksu; Gonul Aciksari; Yusuf Yilmaz; Seref Kul; Mustafa Caliskan
Journal:  Int J Cardiovasc Imaging       Date:  2016-08-13       Impact factor: 2.357

Review 3.  Endothelial dysfunction in inflammatory bowel diseases: Pathogenesis, assessment and implications.

Authors:  Dorota Cibor; Renata Domagala-Rodacka; Tomasz Rodacki; Artur Jurczyszyn; Tomasz Mach; Danuta Owczarek
Journal:  World J Gastroenterol       Date:  2016-01-21       Impact factor: 5.742

4.  Echocardiographic epicardial fat thickness measurement: A new screening test for subclinic atherosclerosis in patients with inflammatory bowel diseases.

Authors:  Kamil Ozdil; Zuhal Caliskan; Nursen Keles; Oguzhan Ozturk; Ahmet Selami Tekin; Resul Kahraman; Levent Doganay; Kenan Demircioglu; Yusuf Yilmaz; Mustafa Caliskan
Journal:  North Clin Istanb       Date:  2017-05-10

5.  Speckle Tracking Stress Echocardiography Uncovers Early Subclinical Cardiac Involvement in Pediatric Patients with Inflammatory Bowel Diseases.

Authors:  Kai O Hensel; Francisca E Abellan Schneyder; Lucia Wilke; Andreas Heusch; Stefan Wirth; Andreas C Jenke
Journal:  Sci Rep       Date:  2017-06-07       Impact factor: 4.379

6.  Correlation of Paraoxonase-1 with the Severity of Crohn's Disease.

Authors:  Katarzyna Szczeklik; Tomasz Mach; Dorota Cibor; Danuta Owczarek; Jacek Sapa; Monika Papież; Jolanta Pytko-Polończyk; Wirginia Krzyściak
Journal:  Molecules       Date:  2018-10-11       Impact factor: 4.411

Review 7.  Characterization of the inflammatory-metabolic phenotype of heart failure with a preserved ejection fraction: a hypothesis to explain influence of sex on the evolution and potential treatment of the disease.

Authors:  Milton Packer; Carolyn S P Lam; Lars H Lund; Mathew S Maurer; Barry A Borlaug
Journal:  Eur J Heart Fail       Date:  2020-06-26       Impact factor: 15.534

Review 8.  Smoking, alcohol and opioids effect on coronary microcirculation: an update overview.

Authors:  Zahra Jalali; Morteza Khademalhosseini; Narjes Soltani; Ali Esmaeili Nadimi
Journal:  BMC Cardiovasc Disord       Date:  2021-04-15       Impact factor: 2.298

9.  Combining patient proteomics and in vitro cardiomyocyte phenotype testing to identify potential mediators of heart failure with preserved ejection fraction.

Authors:  Roseanne Raphael; Diana Purushotham; Courtney Gastonguay; Marla A Chesnik; Wai-Meng Kwok; Hsiang-En Wu; Sanjiv J Shah; Shama P Mirza; Jennifer L Strande
Journal:  J Transl Med       Date:  2016-01-20       Impact factor: 5.531

10.  Lipid profile, atherogenic indices, and their relationship with epicardial fat thickness and carotid intima-media thickness in celiac disease.

Authors:  Zuhal Caliskan; Kenan Demircioglu; Suleyman Sayar; Resul Kahraman; Ozge Caklili; Fatma Betul Ozcan; Osman Kostek; Omer Faruk Baycan; Hamdi Levent Doganay; Mustafa Caliskan
Journal:  North Clin Istanb       Date:  2019-09-02
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.